Travere Therapeutics, Inc. · NASDAQ:TVTX

Dube Eric M sold 400,000 Travere Therapeutics, Inc. shares (Form 4)

Traded Sep 15 to Sep 17, 2026 · Filed Sep 17, 2026

From Sep 15 to Sep 17, 2026, Dube Eric M (Director, CHIEF EXECUTIVE OFFICER) sold 400,000 Travere Therapeutics, Inc. shares at an average US$63.48 for US$25.4M under a trading plan, leaving 432,886 shares. Filed Sep 17, 2026 (Form 4).

Sold
400,000 shares
Price
US$63.48 average (US$61.99 to US$65.31)
Value
US$25.4M
Holding after
432,886 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CHIEF EXECUTIVE OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common StockOption exercise95,666US$23.34528,552Direct
Sep 15, 2026Common StockSale63,498US$61.99465,054Direct
Sep 15, 2026Common StockSale28,796US$62.66436,258Direct
Sep 15, 2026Common StockSale3,102US$63.64433,156Direct
Sep 15, 2026Common StockSale270US$65.31432,886Direct
Sep 16, 2026Common StockOption exercise195,841US$23.34628,727Direct
Sep 16, 2026Common StockSale99,716US$63.26529,011Direct
Sep 16, 2026Common StockSale96,125US$63.64432,886Direct
Sep 17, 2026Common StockOption exercise108,493US$23.34541,379Direct
Sep 17, 2026Common StockSale101,691US$64.59439,688Direct
Sep 17, 2026Common StockSale6,802US$64.95432,886Direct

Source

View original at SEC

Related